Related Experiment Videos
Lipoprotein(a) status in coronary heart disease
Insights
Patients with coronary heart disease (CHD) have significantly higher levels of lipoprotein(a) [Lp(a)] and other lipids. Elevated Lp(a) is crucial for assessing CHD risk and understanding its role in atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
- Lipidology
Background:
- Coronary heart disease (CHD) is a major global health concern.
- Lipid and lipoprotein profiles are key indicators in cardiovascular risk assessment.
- Lipoprotein(a) [Lp(a)] is an emerging risk factor for atherosclerosis.
Purpose of the Study:
- To compare lipid and lipoprotein levels, particularly Lp(a), between patients with CHD and control subjects.
- To investigate the association between specific lipid parameters and the presence of CHD.
- To evaluate the clinical significance of Lp(a) in the context of CHD.
Main Methods:
- Serum samples were analyzed from 37 patients with CHD and 25 age-matched controls.
- Measurements included total cholesterol, triglycerides, HDL-C, LDL-C, VLDL-C, apo A1, apo B, and Lp(a).
- Statistical analysis was performed to compare levels between groups.
Main Results:
- Significant differences (P < 0.001) were observed in lipid and apolipoprotein ratios between CHD patients and controls.
- Lp(a) and several other lipid parameters were significantly elevated in CHD patients.
- HDL-C and apo B levels were significantly lower in CHD patients (P < 0.001).
Conclusions:
- Elevated Lp(a) levels are strongly associated with coronary heart disease.
- Lp(a) plays a significant role in the process of atherogenesis.
- Lp(a) should be considered a critical marker for assessing an individual's risk of developing CHD.
Objective:
To compare the magnitude of lipid, and lipoproteins, especially the lipoprotein(a) [Lp(a)], in controls and patients with coronary heart disease (CHD).
Methods:
Serum total cholesterol, triglyceride, HDL-C, LDL-C, VLDL-C, apo A1, apo B, and Lp(a) levels were determined in 37 patients with CHD and 25 age matched control subjects.
Results:
A significant difference (P < 0.001) in lipid and apolipoprotein ratios were found. Lp(a) and other lipid parameters were found significantly high (P < 0.001) with the exception of HDL-C and apo B which were significantly low (P < 0.001) in CHD patients.
Conclusions:
Elevated levels of Lp(a) suggest not only its role in atherogenesis, leading to CHD, but also that Lp(a) should be given due consideration while assessing CHD risk.